ReviewFrontiers in immunology2026
Gut microbiota and its metabolites with thyroid diseases: functions and mechanisms.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of sex and gender in autoimmune thyroid diseases: mechanisms and knowledge gaps.Reviews in endocrine & metabolic disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut microbiota, a complex and dynamic ecosystem of microorganisms residing in the gastrointestinal tract, has emerged as a critical regulator of human physiology, extending its influence far beyond digestion. Recent advances have illuminated the existence of a bidirectional communication network known as the "gut-thyroid axis" which posits that the intestinal microbial community and its vast repertoire of bioactive metabolites are fundamental modulators of thyroid health and disease pathogenesis. This comprehensive academic review synthesizes current evidence to elucidate the multifaceted functions and mechanisms through which gut microbiota and its metabolites, such as short-chain fatty acids, secondary bile acids, and lipopolysaccharides, impact thyroid disorders. We detail how these microbial components regulate systemic immunity, influence thyroid hormone metabolism, maintain intestinal barrier integrity, and modulate nutrient absorption, thereby contributing to the development and progression of autoimmune thyroid diseases, thyroid dysfunction, and potentially thyroid cancer. Furthermore, the review discusses the translational implications of this knowledge, including the potential for microbiota-targeted interventions like probiotics, prebiotics, and dietary modifications as adjunctive strategies in thyroid disease management. By integrating findings from human studies and animal models, this review aims to provide a mechanistic framework for understanding the gut-thyroid connection and to highlight promising avenues for future research and precision medicine approaches in endocrinology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.